Lolmaugh Cabell 4

4 · TILE SHOP HOLDINGS, INC. · Filed Mar 3, 2026

Form 4

Period: 2026-03-02

DirectorChief Executive Officer

Transactions

Award
Stock Option (Right to Buy)
[F3]
2026-03-02+120,000→ 120,000 total
Exercise: $3.41Exp: 2036-03-02→ Common Stock (120,000 underlying)

Holdings

Common Stock
[F1][F2]
197,814
Stock Option (Right to Buy)
[F4]
Exercise: $8.50Exp: 2027-11-06→ Common Stock (26,900 underlying)
26,900
Stock Option (Right to Buy)
[F4]
Exercise: $5.55Exp: 2028-02-22→ Common Stock (56,000 underlying)
56,000
Stock Option (Right to Buy)
[F4]
Exercise: $6.26Exp: 2029-02-20→ Common Stock (97,067 underlying)
97,067

Footnotes (4)

[F1]Includes (i) 6,173 shares of restricted stock for which the risks of forfeiture will lapse on 3/6/26; (ii) 10,083 shares of restricted stock for which the risks of forfeiture will lapse in equal annual installments on each of 3/4/26 and 3/4/27; (iii) 13,542 shares of restricted stock for which the risks of forfeiture will lapse in equal annual installments on each of 3/3/26, 3/3/27 and 3/3/28; and
[F2](iv) the following shares of performance-based restricted stock, which are, in each case, subject to Mr. Lolmaugh remaining in continuous employment with the Issuer through December 31 of the year preceding the applicable vesting date and the Issuer achieving its performance target for each respective year: (A) 12,099 shares for which the risks of forfeiture will lapse on the date the Issuer releases its annual financial statements for the 2026 fiscal year; and (B) 10,833 shares for which the risks of forfeiture will lapse as to 30% and 40% of the initial number of shares granted on each of the dates the Issuer releases its annual financial statements for the 2026 and 2027 fiscal years, respectively. The Issuer's Form 10-K for the year ended December 31, 2025 contains additional information regarding the applicable performance targets.
[F3]The options vest in three substantially equal installments on each of 3/2/2027, 3/2/2028 and 3/2/2029, subject to continuous employment as of the applicable vesting date.
[F4]Fully exercisable.

Signature

/s/ Mark B. Davis, as Attorney-in-Fact|2026-03-03

Documents

1 file